Ortiz S, Hull C
Microbiol Mol Biol Rev. 2024; 88(1):e0019623.
PMID: 38440970
PMC: 10966950.
DOI: 10.1128/mmbr.00196-23.
Hughes E, Tuck L, He Z, Ballou E, Wallace E
bioRxiv. 2023; .
PMID: 37398450
PMC: 10312749.
DOI: 10.1101/2023.06.14.543486.
Vij R, Cordero R, Casadevall A
mSphere. 2018; 3(6).
PMID: 30404928
PMC: 6222054.
DOI: 10.1128/mSphere.00534-18.
Watkins R, King J, Johnston S
Microorganisms. 2017; 5(4).
PMID: 28974017
PMC: 5748574.
DOI: 10.3390/microorganisms5040065.
Giles S, Dagenais T, Botts M, Keller N, Hull C
Infect Immun. 2009; 77(8):3491-500.
PMID: 19451235
PMC: 2715683.
DOI: 10.1128/IAI.00334-09.
Caring for pets of immunocompromised persons.
Angulo F, Glaser C, Juranek D, Lappin M, Regnery R
Can Vet J. 1995; 36(4):217-22.
PMID: 17424395
PMC: 1686928.
Evidence that Cryptococcus neoformans is melanized in pigeon excreta: implications for pathogenesis.
Nosanchuk J, Rudolph J, Rosas A, Casadevall A
Infect Immun. 1999; 67(10):5477-9.
PMID: 10496933
PMC: 96908.
DOI: 10.1128/IAI.67.10.5477-5479.1999.
Recovery of Cryptococcus neoformans from the nasopharynx of AIDS patients.
Sukroongreung S, Eampokalap B, Tansuphaswadikul S, Nilakul C, Tantimavanich S
Mycopathologia. 1999; 143(3):131-4.
PMID: 10353208
DOI: 10.1023/a:1006909532185.
The invasive behaviour of Cryptococcus neoformans: a possibility of direct access to the central nervous system?.
Gomes N, Boni M, Primo C
Mycopathologia. 1997; 140(1):1-11.
PMID: 9608719
DOI: 10.1023/a:1006809522931.
Anticryptococcal activity by alveolar macrophages from rats treated with cortisone acetate during different periods of time.
Gross N, Chinchilla M, Camner P, Jarstrand C
Mycopathologia. 1996; 136(1):1-8.
PMID: 9144951
DOI: 10.1007/BF00436653.
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.
Mitchell T, Perfect J
Clin Microbiol Rev. 1995; 8(4):515-48.
PMID: 8665468
PMC: 172874.
DOI: 10.1128/CMR.8.4.515.
Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.
Currie B, Freundlich L, Casadevall A
J Clin Microbiol. 1994; 32(5):1188-92.
PMID: 7914203
PMC: 263640.
DOI: 10.1128/jcm.32.5.1188-1192.1994.
Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.
Henderson D, Bennett J, Huber M
J Clin Invest. 1982; 69(5):1185-90.
PMID: 7068854
PMC: 370184.
DOI: 10.1172/jci110555.
Immunity in cryptococcosis: an overview.
Fromtling R, Shadomy H
Mycopathologia. 1982; 77(3):183-90.
PMID: 7040977
DOI: 10.1007/BF00518804.
Particle size of airborn Cryptococcus neoformans in a tower.
Ruiz A, Bulmer G
Appl Environ Microbiol. 1981; 41(5):1225-9.
PMID: 7020595
PMC: 243893.
DOI: 10.1128/aem.41.5.1225-1229.1981.
Technique for the purification of the hyphae of Filobasidiella neoformans.
Zimmer B, Hempel H, Goodman N
Mycopathologia. 1981; 73(3):171-6.
PMID: 7012636
DOI: 10.1007/BF00575088.
Pathogenicity of the basidiospores of Filobasidiella neoformans.
Zimmer B, Hempel H, Goodman N
Mycopathologia. 1984; 85(3):149-53.
PMID: 6738667
DOI: 10.1007/BF00440944.
Pulmonary cell response in mice following intranasal instillation with Cryptococcus neoformans.
Anderson D, Dykstra M
Mycopathologia. 1984; 86(3):179-84.
PMID: 6382016
DOI: 10.1007/BF00441130.
Cryptococcal meningitis presenting as uveitis.
Stone S, Bendig J, Hakim J, Kinnear P, Azadian B
Br J Ophthalmol. 1988; 72(3):167-70.
PMID: 3355802
PMC: 1041399.
DOI: 10.1136/bjo.72.3.167.
Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
Anderson D, Sagha H
Mycopathologia. 1988; 104(3):163-9.
PMID: 3070384
DOI: 10.1007/BF00437432.
